XML 124 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment Net sales and profit by reportable segment for the years ended December 31, 2019, 2018 and 2017 are as follows:
 
Years Ended December 31,
 
2019
 
2018
 
2017
 
(In thousands)
Segment Net Sales
 
 
 
 
 
Codman Specialty Surgical
$
996,206

 
$
963,929

 
$
720,301

Orthopedics and Tissue Technologies
521,351

 
508,512

 
467,935

Total revenues
$
1,517,557

 
$
1,472,441

 
$
1,188,236

Segment Profit
 
 
 
 
 
Codman Specialty Surgical
$
395,019

 
$
363,336

 
$
292,971

Orthopedics and Tissue Technologies
144,638

 
149,510

 
129,697

Segment profit
539,657

 
512,846

 
422,668

Amortization
(27,028)

 
(21,160)

 
(20,370)

Corporate and other
(418,869
)
 
(380,688
)
 
(357,494
)
Operating income
$
93,760

 
$
110,998

 
$
44,804


The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.
The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:
 
United States*
 
Europe
 
Asia Pacific
 
Rest of the World
 
Consolidated
 
(In thousands)
Total revenue, net:
 
 
 
 
 
 
 
 
 
2019
$
1,077,379

 
$
197,468

 
$
157,391

 
$
85,319

 
$
1,517,557

2018
1,045,887

 
201,354

 
144,253

 
80,947

 
1,472,441

2017
894,260

 
150,147

 
80,636

 
63,193

 
1,188,236

Total long-lived assets:
 
 
 
 
 
 
 
 
 
2019
$
383,652

 
$
47,325

 
$
8,598

 
$
7,143

 
$
446,718

2018
280,382

 
32,679

 
3,765

 
3,203

 
320,029

* Includes long-lived assets in Puerto Rico.